A new trading day began on Tuesday, with Transmedics Group Inc (NASDAQ: TMDX) stock price up 2.31% from the previous day of trading, before settling in for the closing price of $64.22. TMDX’s price has ranged from $63.42 to $177.37 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 95.07%. Meanwhile, its annual earnings per share averaged 226.39%. With a float of $32.43 million, this company’s outstanding shares have now reached $33.56 million.
Let’s determine the extent of company efficiency that accounts for 584 employees. In terms of profitability, gross margin is 59.29%, operating margin of 7.84%, and the pretax margin is 8.14%.
Transmedics Group Inc (TMDX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Transmedics Group Inc is 3.39%, while institutional ownership is 109.83%. The most recent insider transaction that took place on Dec 02 ’24, was worth 93,658. In this transaction Chief Commercial Officer of this company sold 1,084 shares at a rate of $86.40, taking the stock ownership to the 20,843 shares. Before that another transaction happened on Nov 11 ’24, when Company’s Chief Commercial Officer sold 1,458 for $90.04, making the entire transaction worth $131,278. This insider now owns 20,843 shares in total.
Transmedics Group Inc (TMDX) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.26 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 226.39% per share during the next fiscal year.
Transmedics Group Inc (NASDAQ: TMDX) Trading Performance Indicators
Here are Transmedics Group Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 7.33. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.93, a number that is poised to hit 0.16 in the next quarter and is forecasted to reach 1.46 in one year’s time.
Technical Analysis of Transmedics Group Inc (TMDX)
Looking closely at Transmedics Group Inc (NASDAQ: TMDX), its last 5-days average volume was 1.5 million, which is a jump from its year-to-date volume of 1.05 million. As of the previous 9 days, the stock’s Stochastic %D was 17.97%. Additionally, its Average True Range was 5.15.
During the past 100 days, Transmedics Group Inc’s (TMDX) raw stochastic average was set at 4.21%, which indicates a significant decrease from 17.16% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.00% in the past 14 days, which was higher than the 84.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $93.94, while its 200-day Moving Average is $121.11. However, in the short run, Transmedics Group Inc’s stock first resistance to watch stands at $67.83. Second resistance stands at $69.96. The third major resistance level sits at $73.47. If the price goes on to break the first support level at $62.19, it is likely to go to the next support level at $58.67. Now, if the price goes above the second support level, the third support stands at $56.55.
Transmedics Group Inc (NASDAQ: TMDX) Key Stats
With a market capitalization of 2.21 billion, the company has a total of 33,562K Shares Outstanding. Currently, annual sales are 241,620 K while annual income is -25,030 K. The company’s previous quarter sales were 108,760 K while its latest quarter income was 4,220 K.
